Abiopharma

🔍 Hori Akio (Executive)

Company: NOMURA HOLDINGS INC (NMR)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Acquired 74 shares of Common Stock at $8.41 per share (Direct)
  Date: 2026-04-24 | Code: A | equity_swap_involved: false | shares_owned_after: 155.15 | transaction_form_type: 4 | Footnotes: F1
• Acquired 6,100 shares of Common Stock (Direct)
  Date: 2026-04-27 | Code: M | equity_swap_involved: false | shares_owned_after: 62,134.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 2,952 shares of Common Stock at $7.71 per share (Direct)
  Date: 2026-04-27 | Code: F | equity_swap_involved: false | shares_owned_after: 59,182.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Sold 6,100 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-27 | Code: M | equity_swap_involved: false | shares_owned_after: 5,500.00 | transaction_form_type: 4 | Footnotes: F2, F5, F2, F6

Footnotes:

• F1: The reported price has been converted into U.S. dollars from Japanese yen using the JPY159.84 = US$1 as spot exchange rate on the Transaction Date, as reported by MUFG Bank, Ltd on April 24, 2026.
• F2: Restricted Stock Units vested on April 1, 2026 and were settled in shares on April 27, 2026.
• F3: Shares were withheld to satisfy tax withholding obligations in connection with the settlement of the Restricted Stock Units.
• F4: The reported price has been converted into U.S. dollars from Japanese yen using the JPY159.56 = US$1 as spot exchange rate on the Transaction Date, as reported by MUFG Bank, Ltd on April 27, 2026.
• F5: Each Restricted Stock Unit represents the right to receive one share of Common Stock.
• F6: No separate Expiration Date.
• REMARKS: CIO (Chief Information Officer)